Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Diabetes, incretin hormones and cardioprotection
Data highlights from the ACHIEVE-1 Phase III trial for Eli Lilly's GLP-1 At 40 weeks, Eli Lilly's orforglipron enabled a superior reduction in A1C compared to placebo
Dihexa, a novel synaptogenic compound, enhances cognitive function in animal models of Alzheimer's disease
M., Kalogjera, L., Vranes, H., Sola, M., Strbe, S., Koprivanac, A., Premuzic Mestrovic, I., & Mestrovic, T
There was a striking side effect: significant weight loss
US$ 22.78
US$ 21.95
US$ 26.89
US$ 24.55
US$ 24.16
US$ 29.43
US$ 25.60
US$ 26.04
US$ 23.72
US$ 21.38
US$ 26.83
US$ 29.33
US$ 27.75
